LNAI Lunai Bioworks Inc.
$0.25▼ -8.18%
Healthcare
Other
Volume 442.5K
Avg Volume (10D) 1.11M
Key Metrics & Fundamentals
Market Cap
$1.27M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.23 - 13.28
% vs 50 MA
-85.02%
% vs 200 MA
-91.54%
RSI-14
14.5
MACD Histogram
-0.0300
Beta (1Y vs SPY)
1.57
Free Cash Flow
-$1.84M
Gross Rev
$31,050
Gross Profit
$31,050
EBITDA
-$2.11M
COGS
$0
Operating Exp
$2.17M
Operating Income
-$2.14M
EBIT
-$2.14M
Pretax Income
-$11.09M
Net Income
-$2.01M
Price & Volume History
Loading chart…
Recent News
Lunai Bioworks Announces Receipt of Nasdaq Determination and Intention to Voluntarily Delist and Deregister
PR Newswire · Oct 22, 2026 7:00 PM ET
Lunai Bioworks (NASDAQ: LNAI) Expands Parkinson's Platform Through Exclusive Tanaist Agreement
PR Newswire · Sep 22, 2026 9:20 AM ET
Lunai Bioworks (Nasdaq: LNAI) Demonstrates AI Chemical-Risk Screening for Generative AI
PR Newswire · Sep 16, 2026 9:25 AM ET
Lunai Bioworks (Nasdaq: LNAI) Names Six Broker-Dealers in Expanded Naked Short Selling Suit
PR Newswire · Aug 27, 2026 9:25 AM ET
Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement with BrainStorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027
PR Newswire · Aug 4, 2026 3:28 PM ET
Lunai Bioworks (Nasdaq: LNAI) Names 10 Defendants in Naked Short Selling Fraud Suit
PR Newswire · Aug 4, 2026 9:20 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See LNAI's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.